Ritter Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in discovery, development and commercialization of some of their therapeutics.
The company stated in the following document that they conduct pre-clinical trials of their drugs on animals.
“The relief in symptoms characterizing acute or chronic cholera toxin-associated enteric disorders provided by the compositions may be observed in standard animal tests for example using the experimental cholera model in the rabbit intestinal loop.” Read the full document
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat gastrointestinal diseases. It focuses on the development and commercialization of RP-G28, which reduces the symptoms associated with lactose intolerance. [Source: MarketWatch]
Company Website: http://www.ritterpharmaceuticals.com